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Appendix S1: MRI acquisition parameters  
 
UKB samples 
MRI images were collected using a 3T Siemens Skyra machine (software platform 
VD13) and a 32-channel head coil (1). The T1 weighted (T1w) images were acquired over 
4:54 minutes, voxel size 1.0x1.0x1.0mm, matrix of 208x256x256mm, using a 3D MPRAGE 
sequence (2), sagittal orientation of slice acquisition, R=2 (in plane acceleration factor), 
TI/TR=880/2000 ms (1). The T2 FLAIR acquisition lasted 5:52 minutes, voxel size 
1.05x1.0x1.0 mm, matrix of 192x256x256 voxels, 3D SPACE sequence (3), sagittal 
orientation, R=2, partial Fourier 7/8, fat saturated, TI/TR=1800/5000ms, elliptical (1).  
 
HCP sample 
T1w and T2 weighted (T2w) images were collected at the Washington University (St 
Louis, Missouri) on a 3T Siemens Skyra scanner using a standard 32-channel head coil (4, 5). 
Two T1w images were acquired, each over 7 minutes and 40 seconds with a voxel size of 
0.7x0.7x0.7mm, matrix/FOV of 224x224x224mm using a 3D MPRAGE sequence (2), 
TR/TE/TI=2400/2.14/1000ms, flip angle 8degrees, R=2, sagittal orientation of slice 
acquisition (6). Similarly, two T2w images were acquired over 8:24 min each, voxel size 
0.7x0.7x0.7mm, matrix of 224x224x224mm, 3DSPACE sequence (3), sagittal orientation, 









Appendix S2: Summary of image processing and QC 
 
Exclusion due to MRI processing in the UKB 
At the time of download (July 2017), T1w images were available for 10,102 
participants of the UK Biobank (UKB) project. None of the participants had withdrawn 
consent after the data was collected. We excluded 175 participants with T1w images labelled 
as unusable by the UKB, leaving 9,928 MRI scans to process. T2 FLAIR images were 
available for 9,755 of those. The FreeSurfer processing failed or did not complete within 48 
hours for a handful of participants: 37 for cortical processing, 19 for subcortical, including 17 
for whom both processing failed. For simplicity, we chose not to re-run image processing on 
these participants as their exclusion should have a minimal impact on the results obtained 
from the full sample. Excluded individuals are described in Dataset S1. Our final sample 
comprised 9,890 participants with usable cortical data, 9,908 with subcortical data and 9,888 
with both cortical and subcortical data. This sample consisted of 9,888 adults aged 62.5 on 
average (SD=7.5, range 44.6–79.6) and comprised 52.4% of female participants. We further 
excluded 391 participants with extreme brains (outliers) or likely to have a large effect on the 
analyses (see below for details about QC). 
Replication data set was downloaded in May 2018 and consisted in an additional 
4,942 participants with a T1w image. Image processing and phenotype selection were 
identical to that of the discovery sample. This led to the exclusion of 381 participants whose 
processing failed and 238 excluded from QC (details below). See Dataset S1 for a full 
description of replication participants (final, QCed and failed processing) in addition to a 
comparison of the discovery and replication samples. 
 
Automated quality control based on the BRM 
The standards in imaging are to perform a visual QC of the processed images 
following a (mostly) automated pipeline. For example, the ENIGMA protocol recommends 
checking participants with outlying measurements but also requires a visual QC of each scan 
to control the cortical and subcortical parcellation 
(http://enigma.ini.usc.edu/protocols/imaging-protocols/). This may prove extremely time 
consuming, especially on large samples such as the UKB that were not available when the 
ENIGMA pipeline was created.  
Here, we propose to utilise the information contained in the BRMs to perform QC. 
We excluded participants showing extreme values on the diagonals of the BRMs 
(diagonal>2.5, we did not observe any heavy left, see Appendix S4). In addition, we 
excluded individuals with outlying off-diagonal elements as they could confound our 
variance component analyses. We took the average of the BRM elements (in absolute value) 
for each individual (i.e. average of ith row of the BRM for the ith individual) and excluded 
participants with a statistic more that 4SD away from the mean. We reported the histograms 
of BRM diagonals and off-diagonals before and after QC (Appendix S4). The arbitrary cut-
off for the BRM diagonal (>2.5) was determined from the HCP sample on which we had 







We applied the same level of QC in the UKB sample but could not compare our approach to 
visual QC exclusion due to the size of the dataset. Instead, we describe the participants 
excluded due to failed processing or QC, to check if their exclusion may impact the results 
presented (Dataset S1).  
 
Comparison of visual vs. BRM-based QC approaches in the HCP sample 
A total of twenty-four participants were excluded in our QC step based on the diagonal 
values (>2.5) or outlying off-diagonal elements in the BRM. Twenty-two participants were 
flagged using each of the BRM QC criteria. More importantly, 20 outlying individuals were 
flagged by both BRM criteria. Thus, participants with outlying brains, as indicated by large 
BRM diagonal values tended to exhibit outlying off-diagonal values (i.e. brain structure 
similarities) with other individuals, potentially causing unstable estimates in variance 
component analyses.  
Out of the 24 individuals excluded in our data driven QC, 14 had also been flagged using the 
ENIGMA visual QC protocol: 3 were fully excluded for incorrect cortical reconstruction, 7 
had an incorrectly segmented hippocampus and 7 others failed visual QC for 3+ cortical 
regions. Finally, our data driven QC did not identify some individuals flagged using the 
ENIGMA visual QC: 4 with incorrect hippocampal reconstruction and 108 with incorrect 
parcellation of the cingulate cortex. The case of the cingulate parcellation is highlighted in 
the ENIGMA QC protocols as its boundary with regions in the frontal cortex are often 
misplaced in FreeSurfer. However, this should not be a problem when working at a vertex 
level as the cortical ribbon remains well segmented, and this may be why these individuals 
are not identified by our QC approach.  
 
Description of excluded participants in the UKB 
We report the mean (SD) or % of each answer (for qualitative variables) for all the 
phenotypes considered from the UKB (Dataset S1) and compare the mean and variances 
between included and excluded participants. We used a conservative Bonferroni significance 
threshold of 1e-4 to account for the number of tests.  
The participants we excluded (either for unusable T1, or QC) were on average more 
than 2.7 years older than the individuals used in the analysis (p-value<3.3e-7) and men were 
over-represented (62% of excluded were men vs. 47%, p-value<1.8e-5). In addition, 
excluded individuals were more variable in term of digit matching reaction time, dried fruit 
intake and exposure to passive smoking. They were less variable than included participants in 
regard to their basophil percentages (Dataset S1).  
Individuals with unusable T1 reported a smaller amount of passive smoking at home 
(0.001 days a week vs. 0.2, p-value=4.7e-9). They were also less variable than individuals 
included in the analysis in term of their depression scores.   
 On the other hand, individuals excluded from QC were 10% less performant as the 
digit matching task than included participants (smaller number of correct matches or 
attempted matches, greater reaction time, p-value<4.8e-7). They also were more likely to be 
diabetics (10% in QCed participants vs. 5%, p-value=1.e-5) and had a reduced acceleration 
force (-2.4m/s-1, p-value=3.5e-5) as well as greater waist circumference (+3.1cm, p-






smaller grey matter volume, hippocampus volumes or cortical thickness. More importantly 
excluded individuals exhibited much greater variances in all brain measurements which 
suggests imperfect/failed processing.  
 
Sample description HCP 
Similar to the results in the UKB, HCP participants excluded by QC showed a 
significantly greater variance in brain measurements than included participants (Dataset S2). 
This further validates our QC approach, suggesting that the participants QCed out exhibit 
outlying brains, some due to failure of the MRI processing pipeline.    
In addition, excluded participants differed (p-value<1e-4) on some aspects of 
cognition: delay discounting $200 at 5 years (smaller mean and variance), spatial orientation 
(total positions; greater variance) and sustained attention (longest run non-response; smaller 
variance), depression scores (smaller mean and variance).  
The similarities between excluded participants in the UKB and HCP (e.g. depression 
scores or cognition) are intriguing. We hypothesise that these phenotypes may be associated 
with greater level of movement in the scanner leading to lower image quality and failed 
processing. Us and others previously showed that inattention and hyperactivity are associated 
with greater movement in resting-state fMRI(7, 8), and a subsequent study in the HCP found 
multiple factors also associated with motion during rs-fMRI (for example: some cognition 
domains, antisocial or somatic scores, weight and BMI as well as tobacco use)(9).  
Note that when the variance in excluded and included participants differs, the sample 
participants may not capture the full phenotypic variance and the results of variance 
component analyses should be interpreted with caution. In other words, we are estimating the 
proportion of in sample variance accounted for by brain features which may differ from the 
proportion of total phenotypic variance accounted for in the population.   
 
QC when comparing the different cortical processing (mesh coarseness and smoothing) 
In this section, we performed a slightly different QC which consisted of excluding 
individuals with extreme off-diagonal BRM elements (+-5SD from mean, option previously 
not available in OSCA). We note that this QC is slightly more stringent but did not change 
the morphometricity estimates reported in the main text (Dataset S3, S12).  
It is important to have a QC that adapts to the distribution of the BRM off-diagonals, 
which may differ depending on the processing options. To note, most of the excluded 









Appendix S3: HCP image processing  
 
The HCP team (6, 10, 11) pre-processed the structural scans to facilitate scan 
comparison across individuals, removing spatial artefacts and improving T1w and T2w 
alignment using FSL (12, 13) and FreeSurfer (14). When both passed HCP quality control 
(QC), T1w and T2w images they processed them together in FreeSurfer 6.0 (14), otherwise 
data extraction relied on a single scan (6). Participants with poor quality T1w and T2w scans 
were re-imaged (6). Cortical processing (recon-all procedure in FreeSurfer) was also 
performed by the HCP team and included down sampling to 1mm size voxels and 
256x256x256 matrix, aided registration using customised brain mask, and two manual steps 
performed outside of the recon-all procedure to enhance white matter and pial reconstruction 







Appendix S4: BRM interpretation 
 
Diagonals of the BRM consist of the mean square of the participants’ vertex-wise 
measurements. Since the vertex-wise data are centred, larger diagonal elements reflect a 
greater proportion of extreme phenotypes, may they be small or large vertex measurements. 
Thus, we can interpret large diagonal values as “outstanding brains” in term of size/shape or 
due to failure in processing (e.g. incorrect cortical or subcortical parcellation). On the other 
hand, small diagonal values indicate small absolute values across the brain measurements 
(mean centred), hence brains close to the average brain. Across all the samples and BRMs, 
we observed that the diagonal elements were centred around 1, and skewed to the right 
(Appendix S4 Figure 1-2).  
Off-diagonal elements of the BRM are the covariances between two individuals’ 
measurements, thus greater values indicate greater similarities between the pair of 
participants. Off-diagonal elements are normally distributed with a mean of 0. Their 
dispersion varies upon the brain modality considered and the degree of correlation between 
the vertices (Appendix S4 Figure 1-2).  
Participant’s brain similarities are thought to reflect (some of) the participants’ 
similarities in genetics and environment, in other words we expect part of the variance 
accounted for by the BRM to be genetic. Indeed, we observed a positive correlation between 
elements of the BRM and of the Genetic Relatedness Matrix (GRM) in the UKB or the 
pedigree matrix in the HCP, which suggests that participants more alike genetically also 
exhibit more similar brains (Appendix S4 Figure 3-4). The GRM was calculated in 
GCTA(15) from the hap-map 3 variants further filtered for MAF>0.01, pHWE<10-6 and 
missingness<0.05 for a total of 1,123,943 variants. The GRM calculation was restricted to 
participants of European ancestry (N=456,426) defined by a >0.9 posterior probability of 
belonging to the 1000G reference ancestry cluster. Overall, the pairs of twins and especially 
monozygotic twins did not exhibit outlying BRM values compared to the unrelated pairs 
(Appendix S4 Figure 4), suggesting that they should not confound the results of a variance 
component analysis. Quite the opposite, they increase the variance of the off-diagonal BRM 









Appendix S4 Figure 1: Histograms of diagonal and off-diagonal elements of the UKB brain relatedness 
matrix.  
Plots are presented before (left panels) and after participants’ QC exclusion (right panels). Colors correspond to 
the different brain modalities: dark red – left cortical thickness, light red – right cortical thickness, dark purple – 
left cortical area, light purple – left cortical area, dark yellow – left subcortical curvature, light yellow – right 







Appendix S4 Figure 2: Histograms of diagonal and off-diagonal elements of the HCP brain relatedness 
matrix.  
Plots are presented before and after participants’ QC exclusion. Colors correspond to the different brain 
modalities: dark red – left cortical thickness, light red – right cortical thickness, dark purple – left cortical area, 
light purple – left cortical area, dark yellow – left subcortical curvature, light yellow – right subcortical 









Appendix S4 Figure 3: Scatterplot showing the correlation between GRM and BRM pairwise elements in 
the UKB sample.  
 Correlations and p-values are shown. Colors correspond to the different brain modalities: dark red – left cortical 
thickness, light red – right cortical thickness, dark purple – left cortical area, light purple – left cortical area, 
dark yellow – left subcortical curvature, light yellow – right subcortical curvature, dark green – left subcortical 










Appendix S4 Figure 4: Boxplot showing the BRM pairwise elements per zygosity group in the HCP.   
Tests of mean differences are shown. Colors correspond to the different brain modalities: dark red – left cortical 
thickness, light red – right cortical thickness, dark purple – left cortical area, light purple – left cortical area, 
dark yellow – left subcortical curvature, light yellow – right subcortical curvature, dark green – left subcortical 







Appendix S5: assumption testing in linear mixed models 
 
We tested whether the variance accounted for by the brain similarities was 
significantly different from 0 using a likelihood ratio test on nested models (with and without 
the random effect). The test statistic follows a chi-square distribution with x degree of 
freedom (x being the number of variance components tested) for a   
  value inside the 
parameter space. However, when testing       
             
    , the p-value should be 
interpreted with caution as the estimator may not be asymptotically normally distributed 
because 0 is a boundary of the parameter space (16, 17). Some have suggested that the p-
value could be better approximated using a mixture of chi-square distributions in the test of 
significance (16, 17). However, a 50:50 mixture has been shown to be sometimes 
inappropriate (18, 19) as the test relies on assumptions often not met in LMM (such as i.i.d. 
observations) (19). Thus, we preferred using a 2 (x df.), the only consequence being a less 
powerful hence conservative test (18-20). Such test is implemented in OSCA (21), as well as 







Appendix S6: SE of the residual correlation 
 
Residual correlation (rE) offers insight into factors, shared between the traits, but that do not 
relate to grey-matter structure (e.g. other brain modalities, non-brain contribution). A 
weighted sum of rGM and rE make up the phenotypic correlation. Thus, we calculated rE from 
the phenotypic and grey-matter correlation using:  
   
         
    
 
      
        
   
 
with   
 and   
  the brain-morphometricity of the two traits included in the bivariate model. 
To derive the SE, we use the fact that the residual correlation between random 
variables X and Y can be expressed as a function of the residual covariance between X and Y 
(    ), and the residual association with X or Y (  
 




   
    
           
 
 
    
 
 
We can derive a first order tri-variate Taylor series approximation around the 
expected values of         
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so, we implicitly assume these numbers are estimated with a reasonable confidence so that 
the Taylor series approximation around the mean holds. Thus,  
 
           
      
        
 
                 
          
  
                
          
 
 
Taking the variance: 
 
       
    
      
  
       
       
       
  
       
       
       
 
            
       
  
            
       
 
        
          
        
 
  
To conclude, approximating the variance of    using the formula above, requires the 
variance components estimates (       
 
        
 
 ) from the bivariate model as well as their 
matrix of sampling variance-covariance for the values 
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Such values are estimated in OSCA/GCTA and may be found in the log files 
outputted during the model fitting. Note that SE of the grey-matter correlation is derived 
using the same approach. The interested readers may refer to (22-24). 
For significance testing, we used a one-sided test based on the test statistic: 
 
      
  
      
 
 






Appendix S7: Power of linear mixed models 
 
Power of the current analyses:  
In the UKB discovery sample (assuming N=9,500), we had 80% power to detect an 
effect >2.2% of variance accounted for by the random effect, while taking into account 
multiple testing (pvalue significance threshold p<0.05/175). In the HCP sample (assuming 
N=1,000), considering the number of tests performed (p<0.05/160), we would need an 
association effect size of 20% of variance to yield the same power (25). For brain 
correlations, the calculation of statistical power depends on the sample size (set to 9,500), the 
variance accounted for in each phenotype (we chose 5%), the phenotypic correlation (set to 
r=0.2), the significance threshold (p<4.2e-5, based on our number of tests) as well as the 
variance of off-diagonal elements of the BRM          (0.00096, for the BRM of all brain 
features) (25). In this example, we had 80% power to detect a brain correlation greater than 
0.35, but only a 7% power for a brain correlation of 0.2. Using a sample of N=1,000, as per 
the HCP, and selecting phenotypes with >20% variance accounted for (everything else being 
equal), we have a 1% power to detect a brain correlation of 0.35, and we would need a brain 
correlation greater than 0.99 to achieve 80% power.   
 
Power derivations for LMMs 
Power calculation of variance component analysis may be derived from the sampling 
variance of the estimate:       
 
), which is the square of the standard error (SE) of the 
estimate. In REML analyses (e.g. GCTA or OSCA) the SE is estimated from diagonal 
elements of the inverse of the information matrix, and it has not been derived analytically. 
Visscher et al.,(25) showed that the SE could be approximated using a simpler model 
formulation known as Haseman Elston (HE) regression(26), which is the ordinal least square 
equivalent of the REML approach. As such, HE regression should be slightly less powerful 
that the REML approach, resulting in a marginal underestimation of the power.   
Briefly, HE regression(26) performs a linear regression of the phenotype pairwise product 
zij=yiyj on the off-diagonal elements of the BRM:    . For a pair of individual i and j:  
                  
This model includes n=N(N-1)/2 pairwise observations and we can easily show that     
  
(25, 26). In this simple linear regression framework, assuming that the     are i.i.d. we can 
calculate the       
           
        
          
.  
For centred and standardised phenotypes Y,            and therefore             Thus, 
      
   
 
               
. As a consequence, the power of variance component analysis may 
be approximated from the sample size N and the variance of the off-diagonal elements of the 
BRM. The same formula holds for discrete outcome variables (e.g. sex or disease status) and 
a similar derivations may be performed for a the bivariate case and the power of brain 
correlation(25). In our UKB and HCP data, we calculated the variance of the off-diagonal 
BRM in order to get an approximation of the SE of our variance component estimates. The 
         were consistent across sample and across the left and right modalities (Appendix 






for GRM(25, 27). Thus, in our UKB imaging sample, the variance of the off-diagonal GRM 
was 2.0e-5 (after removing related individuals with GRM elements>0.05), consistent with 
previous report and analytic derivations from our group(25, 27).  
We tried to validate the derivations presented above using simulation. Thus, we simulated 
100 normally distributed phenotypes (mean 0, variance 1) and estimated the SE of the 
variance components using OSCA, varying the sample size (from N=500 to 9,000). We used 
random subsets of the BRM calculated from the UKB data for the variance-covariance of the 
random effect. We conducted such analysis for the 8 brain modalities as well as for the global 
BRM. Results of simulation and approximation theory are presented in Appendix S7 Table 
1, Appendix S7 Figure 1 and 2, and suggest that the approximation yields realistic, though 
slightly underestimated, values for the SE of the variance component estimates. Note that HE 
regression is known to produce underestimated SE at high power as the i.i.d. assumption of 
errors does not hold anymore(28). Despite being small, the underestimation of SE may lead 
to overestimate the statistical power using the approximation theory. To circumvent this 
problem, we provide values for         , derived from our simulation analysis, that result in 
realistic power calculation using the approximation theory (Appendix S7 Table 1). The 
statistical power may be calculated (for a hypothesised variance accounted for:   
  and a 







  using the R formula 1-pchisq(qchisq(1-, df), df, ncp) or the GCTA-GREML online 
power calculator (http://cnsgenomics.com/shiny/gctaPower/). 
Results presented below also highlight the greater power of the brain variance component 
analyses compared to estimation of SNP heritability, as indicated by the smaller SE of the 
estimates. For example, in a sample of N=1000, we would have >60% power to detect an 
effect    
      (with =0.05), but only a 5.5% power to detect a SNP heritability greater 








  Var(Bij) UKB Var(Bij) HCP Var(Bij) to use in power 
calculation (corrected 
based on our simulations) 
cortical area Left 0.0012 0.0015 0.00047 
 right 0.0012 0.0016 0.00046 
Cortical thickness Left 0.0049 0.0021 0.0017 
 Right 0.0057 0.0024 0.0017 
Subcortical curvature Left 0.057 0.057 0.017 
 Right 0.058 0.059 0.017 
Subcortical thickness Left 0.035 0.036 0.018 
 right 0.034 0.035 0.020 
All modalities  0.0017 0.0014 0.00096 
Appendix S7 Table 1: Variance of off-diagonal elements in the UKB and HCP.  
Following our simulation results and to avoid overestimating the statistical power of brain variance-component analysis, we recommend using the values in the 
right-hand side column in the approximation theory formula (see main test for the formula, or http://cnsgenomics.com/shiny/gctaPower/ for online power 










Appendix S7 Figure 1: Empirical and approximated SE of the variance component estimates using BRM and GRM 
The right panel is a close up of the left one, restricted to sample sizes above 2000 participants. We did not calculate the empirical power for the genetic case has 








Appendix S7 Figure 2: Statistical power of detecting an association R
2
>5%, with a risk alpha=0.05.  
Power derived from simulation and from the approximation theory are compared. We did not calculate the empirical power for the genetic case has it has already 






Appendix S8: Including (or not) twins when estimating morphometricity 
 
The HCP comprises many twin pairs (thus, non-independent observations), and we 
evaluated the impact of their exclusion on the morphometricity estimates. We found a good 
agreement of the results with and without including related individuals, with no evidence of 
systematic bias, though the limited power (N=444) results in wide SE (~0.20) (Appendix 
S8 Figure1).  
The reason why LMM are robust to the presence of related individuals may be that 
they explicitly model the grey-matter relatedness in all analyses, which should account for 
the grey-matter resemblances arising from shared genetics or environment. For another 
confirmation, our results on the full HCP sample yielded always similar (e.g. Fluid IQ) or 
lower (e.g. attention) brain-morphometricity estimates than reported by Sabuncu et al., who 
selected 1 subject per family (29). To note, grey-matter similarities of twin pairs is not as 
outlying as their genetic relatedness factor (compared to the general population) (Appendix 
4). 
  
Appendix S8 Figure1: Morphometricity estimates in the HCP sample obtained using the full sample or 
a reduced set of unrelated individuals. 
Only phenotypes with significant morphometricity are included here. Overall correlation between estimates is 
0.8 with no evidence of systematic bias when including all family members. The largest differences were 
found for variables with little variation (opiates) or non-normally distributed (times used tobacco, ASR score, 








Appendix S9: In depth results and discussion of the ROI-traits associations using the 
vertex-wise resolution 
 
In the UKB, the largest associations were observed between age of the participants 
and subcortical volumes (R
2
 ranging between 0.22 and 0.35 for subcortical thickness, 0.20 
0.38 for subcortical area), but most cortical regions were also significantly associated with 
age, albeit to a lesser extent (R
2
 in the 0.0083-0.15 range for cortical thickness, 0.0048-0.15 
range for cortical surface area). Next, significant ROI associations included sex, associated 
with all subcortical volumes (R
2
 in the 0.0049-0.024 range for thickness, 0.0058-0.027 for 
area) and with many cortical regions (R
2
 in the 0.0011-0.0076 range for cortical thickness, 
0.0019-0.014 for cortical surface area) (Figure S8 and Dataset S7). Maternal smoking 
around birth was further associated with 28 ROI, mostly located in the occipital and 
temporal lobes (R
2
 in the 0.013-0.026 range with cortical thickness, R
2
 in 0.014-0.071 with 
cortical surface and R
2
 in the 0.010-0.039 range with subcortical structure). In addition, we 
found significant associations between cognition domains and structure of thalamus, 
putamen, pallidum and hippocampus (R
2
 in the 0.0043-0.024 range).  Notably, fluid 
intelligence was associated with all aspects of thalamus anatomy (left and right, thickness 
and surface area) while the other cognition domains considered were associated with some 
aspects of thalamus structure. No association between cognition and cortical structure 
survived multiple testing correction.  
Diabetes diagnosis correlated with (left) superior frontal surface area (R
2
=0.054), as 
well as with thalamus, putamen, and pallidum thickness (R
2
 ranging between 0.0067 and 
0.015), or thalamus and hippocampus surface (R
2
 in the 0.0061-0.014 range). Alcohol 
intake was associated with left thalamus thickness (R
2
=0.018) while smoking status and 
past tobacco use were associated with thalamus, caudate, putamen and pallidum thickness, 
as well as with thalamus surface area (R
2
 in the 0.007-0.020 range). Finally, we also 
observed small associations between cortical or subcortical regions and overall health 
rating, time spend watching TV, body fat percentage and physiological measurements 
(Figure S8).  
Using the replication UKB sample, we replicated 633 out of the 975 significant 
ROI-trait associations (p<0.05/975). Most associations were found with age, sex and body 
size variables, though we also replicated associations between subcortical volumes and 
hand grip strength or time spent watching TV (Dataset S9). In addition, the magnitude of 
the associations with age, and body size were greatly similar between discovery and 
replication analyses (Appendix S9 Figure1). For sex, we observed larger ROI associations 
in the UKB replication sample (Appendix S9 Figure 1), consistent with the larger brain-
morphometricity observed in this sample (Figure S6).  
 In the HCP sample, age was associated with thickness (R
2
 in the 0.020-0.049 range) 
and surface area (R
2
 ranging between 0.067-0.10) throughout the cortex, as well as with 
subcortical structure (R
2
 in the 0.016-0.087 range). Sex was associated with cortical 
thickness of the lateral orbitofrontal cortex (R
2 
in the 0.059-0.073 range), as well as with 
subcortical structure (R
2






between cocaine, opiate or hallucinogens use and surface area of several cortical regions 
located in the temporal lobe (fusiform, superior temporal, insula), frontal (pars-triangularis, 
pars-opercularis, caudal-middle frontal), parietal (supramarginal, superior and inferior-
parietal, precuneus) or in the cingulate (R
2 
in the 0.25-1.00 range for cocaine test, R
2
 in the 
0.43-0.46 range for opiates, R
2
 in 0.25-0.56 for number of times used hallucinogens). 
However, the small numbers and possible outliers in the vertex-wise measurements make 
such associations prone to false positives. Alcohol consumption was also associated with 
surface are of the frontal cortex (right rostral middle frontal, paracentral and precentral gyri, 
R
2
 in the 0.28-0.36 range). No other association survived multiple testing correction 
(Appendix S9 Figure2 and Dataset S10).  
 Body size variables were strongly associated with subcortical structure under the 
baseline model (R
2
 ranging between 0.010-0.059 for height, R
2
 between 0.048-0.30 for the 
others) and to a lesser extent with cortical surface area (R
2
 between 0.0078-0.026 for 
height, R
2
 between 0.0061-0.060 for the others) and cortical thickness (R
2
 in 0.0039 0.016 
for height, R
2
 in 0.0017 0.045 for the others).  The associations between grey-matter 
structure and body size were pervasive (72/164 significant ROIs associations with height, 
109 with waist circumference, 105 with BMI) (Figure S9, Dataset S8), suggesting that 




 Our results for sex are consistent with results from the UKB first release (N=5,216, 
using ROI average (30)), while several studies have previously reported associations 
between BMI and several grey-matter measurements (31-36). 
In the UKB, smoking status was associated with thickness and surface of the 
thalamus (left and right), although we also found associations with the caudate and 
pallidum. Previous studies have reported association between tobacco usage and volume of 
left thalamus (37-39), which might be due to faster age related volume loss in smokers (40). 
We did not replicate other cortical or subcortical associations previously reported (37, 38, 
41). Alcohol intake was also associated with left thalamus thickness in the UKB, consistent 
with the significant grey-matter correlation (Figure 3) between the two traits. The thalamus 
has been implicated in alcohol-related neurological complications (e.g. Korsakoff’s 
syndrome)(42) but may also be associated with regular alcohol usage (42, 43) or alcohol 
use disorder (44). Maternal smoking around birth was further associated with the thalamus, 
putamen, hippocampus and pallidum, as well as temporal and occipital ROIs. In addition, 
diagnosis of diabetes was associated with area of the left superior-frontal cortex (Dataset 
S7, Figure S8). Nervous system complications of diabetes (sometimes labelled diabetic 
encephalopathy) are widely accepted (45) but little is known about the specific brain 







Appendix S9 Figure 1: ROI based associations between UKB discovery and replication samples 
for selected phenotypes. 
Each panel correspond to a single phenotype, and displays the association R2 of this phenotype with 
each ROI of interest considered. The results found in the replication sample (Y-axis) are plotted as a 
function of the discovery results (X-axis). The labels indicate which ROI corresponds to which point in 








Appendix S9 Figure 2: Region Of Interest (ROI) based LMMs in the HCP.  
Significant association R
2
 between each UKB phenotype associated with grey-matter shape in Figure 1b and the grey-matter vertices from each of 









Fig. S1. Replication R2 (or correlations) are presented as a function of the discovery 
R2 (or correlation).  
The R2 or correlations correspond to the fixed effect association between a covariate and all other 
phenotypes (labelled in plots). For example, panel a) shows the association R2 between age and all 
phenotypes, in the discovery and replication UKB samples. Panel b) shows the same results but using 
correlations and not R2 to appreciate the sign. Panels, c) and d) show the R2 and correlations between 
sex and all other variables. Panel e) presents the R2 between phenotypes and head size (ICV, left and 
right total thickness and area). Panel f) presents the R2 between phenotypes and body size (height, 
weight and BMI). As head size or body size are composed of several variables, only the R2 is 







Fig. S2. Morphometricity of brain phenotypes – positive controls 
As a positive control, we estimated the association between all grey-matter vertices and 
global measures of brain size, controlling for acquisition age and sex. Results are shown 







Fig. S3:  Morphometricity in the UKB replication sample under baseline covariates. 
Panel a) presents the summary of the replication analysis in the UKB. Only the 58 significant phenotypes from the UKB discovery 
sample were included in the analysis and are shown here. Black bars correspond to 95% confidence intervals. Phenotypes showing 
significant morphometricity in the replication sample (p<0.05/58) are labelled in black. To note, the replication sample was only half 
the size of the discovery one, with a clear incidence on power (and 95%CIs).  Blood assay variables and being part of multiple birth 
suffered from a small number of observations (N~300), which explains the even larger confidence intervals.  Panel b) compares the 
replication morphometricity estimates (X axis) to the discovery ones (Y-axis). We excluded blood assay variables, for which the small 
N led to unstable parameter estimation. We found a great concordance of results between the 2 independent UKB samples as indicated 







Fig. S4: Scatterplots of association R
2
 from LMMs, comparing results when fitting a single BRM versus 4 BRMs corresponding to 
all different brain modalities (cortical thickness, cortical surface area, subcortical thickness and subcortical curvature).  
Panel (a) shows the results for the UKB sample, panel (b) shows the results for the HCP sample. Note that fitting multiple variance 
components comes at an increased computational cost and a slightly increased standard error of the estimate of the overall variance 
explained(47). In addition, when modelling 5 variance components, the AI-REML algorithm failed to converge for 58 UKB phenotypes and 
71 HCP phenotypes (in particular for phenotypes with low morphometricity) because of the increased uncertainty in the estimate of variance 
explained by each component due to smaller number of brain measurements in an individual component in comparison with the total. The 
correlation between the association R
2







Fig. S5: Effect of correcting for body size on morphometricity estimates. Scatterplots of association R
2 
for all the phenotypes before 
and after correcting for body-size variables.  
 









Fig. S6: Morphometricity estimates correcting for height, weight and BMI in addition 
to baseline covariates, in the UKB replication sample (X-axis) and the UKB discovery 
sample (Y-axis). 
 
Only phenotypes displaying significant morphometricity in the UKB discovery set are 







Fig. S7: Grey-matter and residual correlations under the baseline model (i.e. not correcting for body size).  
 
Estimates are shown for the UKB (panel a) and HCP (b). Grey-matter correlation is shown above the diagonal, and residual correlation 








Fig. S8: Region Of Interest (ROI) based LMMs in the UKB.  
 
Plot displays the significant association R2 between each UKB phenotype associated with grey-matter shape in Figure 1a and the grey-
matter vertices from each of the Desikan (48) atlas ROI. Results include baseline covariates as well as height, weight and BMI. 
 
 
Fig. S9: Region Of Interest (ROI) based LMMs in the UKB for body size variables 








Figure S10: Effect of cortical mesh smoothing and mesh choice on the brain-
morphometricity estimates (UKB replication samples). 
 
Blood assay Variables (with n<500 observations) were excluded from the analysis due to unstable 








Fig. S11: Scatter plot comparing, for each UKB phenotype, our association R2 from 
vertex-wise processing and that obtained from standard ENIGMA ROI based 
processing. 
 
All the points are above the diagonal indicate a greater amount of information retained 
using the vertex-wise processing compared to the ROI based dimension reduction 




























Figure S12: In sample and out of sample prediction accuracy as a function of the total 
association R
2
 (baseline covariates) 
 








Figure S13: Prediction accuracy of BLUP and LASSO brain scores.  
 
Models were trained and evaluated by controlling for baseline covariates on the UKB 
discovery sample. We evaluated prediction R
2
 in the UKB replication sample. Confidence 







Table S1. Replication of grey-matter correlations identified in the UKB discovery 
sample   
Variable 1 Variable 2 Discovery Replication 
  rGM  rGM  SE pvalue 
Fluid intelligence Max digits attempted 0.71 1.0 7.3 0.29469 
Fluid intelligence 
Number correct symbol 
matches 0.72 1.0 25.1 0.31246 
Max digits attempted 
Number correct symbol 
matches 1.0 1.0 25.1 0.31246 
Fluid intelligence Cheese intake 1.0 0.82 0.2 0.0015689 
Time spent outdoors 
summer 
Time spent outdoors 
winter 1.0 1.0 0.2 0.1928 
Time spent watching 
television Body fat percentage 0.73 0.81 0.2 4.42E-05 
Frequency vigorous activity Acceleration force 1.0 0.62 0.4 0.13604 
Overall health rating Pulse rate 1 1.0 1.0 0.5 0.01224 
Overall health rating Pulse rate 2 1.0 1.0 0.5 0.012028 
Pulse rate 1 Pulse rate 2 0.99 1.0 0.01 0.00049312 
Overall health rating Waist circumference 1.0 0.39 0.4 0.19506 
Body fat percentage Waist circumference 0.52 0.45 0.2 0.02677 
Pulse rate 1 Waist circumference 0.67 0.31 0.3 0.1675 
Pulse rate 2 Waist circumference 0.73 0.56 0.3 0.047662 
Hand grip strength left Hand grip strength right 0.92 0.84 0.06 1.76E-07 
Body fat percentage Forced vital capacity -0.66 -0.45 0.2 0.026155 
Hand grip strength right Forced vital capacity 0.69 0.70 0.2 0.0015424 
Fluid intelligence 
Forced expiratory 
volume 1.0 0.48 0.3 0.062686 
Hand grip strength right 
Forced expiratory 
volume 1.0 0.79 0.2 0.00044463 
Body fat percentage Basal metabolic rate -0.69 -0.75 0.1 3.89E-06 
Pulse rate 1 Basal metabolic rate -0.55 -0.46 0.2 0.038444 
Waist circumference Basal metabolic rate -0.75 -0.55 0.2 0.0055741 
Smoking Status Past tobacco use -0.98 -0.93 0.03 0.0011549 
Alcohol intake 
Amount alcohol drunk 
typical day -0.89 -1.0 0.1 0.00042018 
Smoking Status 
Amount alcohol drunk 
typical day 0.71 1.0 0.2 0.0044935 
Past tobacco use 
Amount alcohol drunk 







Table S2: Summary of the prediction accuracy (R
2
) of the BLUP grey-matter scores.  
We constructed BLUP scores for the 39 UKB variables showing significant morphometricity and evaluated their predictive power in the UKB (10 fold-
cross validation) and HCP sample. When the phenotype corresponding to the grey-matter score was not available in the HCP, we chose the closest 
available (e.g. waist circumference grey-matter score evaluated against BMI). We evaluate the prediction accuracy by fitting GLM controlling for height, 
weight and BMI as well as for the baseline covariates (acquisition, age, sex and head size); except for (#) denoting associations not controlling for height, 
weight and BMI. Rows in bold indicate significant association after correcting for multiple testing (p<0.05/39=1.3e-3) both in and out of sample. 
 In sample prediction (UKB) Prediction into UKB replication Out of sample prediction (HCP) 
 r pvalue R
2
 AUC (SE) r pvalue R
2




 AUC (SE) 
Haemoglobin 
concentration 0.05  1.6e-05 0.0025  0.035  5.5e-01 0.0013  Hemoglobin A1C 0.015 6.8e-01 <0.001  
Haematocrit % 0.077  1.4e-10 0.006  0.037  5.7e-01 0.0013  Hematocrit level 1 0.061 2.1e-02 0.0037  
White blood cell 
count 0.042  2.2e-03 0.0018  0.016  3.4e-01 <0.001  Hematocrit level 1 
-
0.00051 9.8e-01 <0.001  
Mean time 
correct matches 0.046  2.0e-06 0.0021  0.053  2.9e-04 0.0028  Crystallised IQ -0.046 9.7e-02 0.0021  
Number correct 
symbol matches 0.09  1.1e-13 0.0081  0.069  2.5e-04 0.0048  Crystallised IQ 0.064 2.2e-02 0.0041  
Max digits 
attempted 0.091  2.9e-14 0.0083  0.083  1.1e-05 0.0069  Crystallised IQ 0.069 1.3e-02 0.0048  
Fluid intelligence 0.077  4.1e-14 0.0059  0.11  7.2e-12 0.011  Fluid IQ 0.027 3.5e-01 <0.001  
Age 0.64  0.0e+00 0.41  0.68  0.0e+00 0.46  Age 0.15 3.1e-08 0.024  
Heel bone 
mineral density 
bmd 0.065  2.1e-06 0.0042  0.058  2.8e-03 0.0034  Age -0.015 5.8e-01 <0.001  
Heel bone 
mineral density 
tscore 0.065  1.8e-06 0.0043  0.056  3.9e-03 0.0031  Age -0.015 5.9e-01 <0.001  
Sex 0.26  0.0e+00 0.067 0.58 (0.0059) 0.33 9.8e-305 0.11 0.8 (0.0064) Sex -0.25 8.0e-42 0.061 0.68 (0.016) 
Cheese intake 0.061  2.0e-09 0.0037  0.076  1.9e-07 0.0058  
SSAGA Education 
level 0.029 3.2e-01 <0.001  
Part of multiple 
birth 0.078  4.1e-14 0.0061 0.66 (0.022) 0.13  1.5e-03 0.016 0.72 (0.065) Being a twin 0.31 1.1e-28 0.098 0.69 (0.016) 
Body fat 
percentage 0.29  0.0e+00 0.085  0.31 7.7e-190 0.095  BMI 0.21 5.6e-13 0.045  
Waist 







vigourous activity 0.044  9.4e-06 0.002  0.033  1.6e-02 0.0011  BMI -0.0015 6.7e-01 <0.001  
BMI 0.45  0.0e+00 0.2  0.45 7.4e-235 0.20  BMI 0.21 2.4e-12 0.042  
Diabetes 
diagnosis 0.062  4.7e-10 0.0038 0.6 (0.014) 0.085  2.5e-09 0.0073 0.63 (0.019) BMI 0.0055 1.0e-01 <0.001  
Overall health 
rating 0.052  8.2e-08 0.0027  0.062  7.8e-06 0.0039  BMI -0.002 5.5e-01 <0.001  
Time spent 
watching 
television 0.083  3.0e-17 0.0068  0.12  1.8e-17 0.014  BMI -0.0025 4.5e-01 <0.001  
Basal metabolic 
rate 0.029  1.0e-24 0.00082  0.031  3.7e-14 <0.001  BMI 0.0046 1.7e-01 <0.001  
Hip 
circumference 0.38  0.0e+00 0.15  0.36 7.3e-143 0.13  BMI 0.21 5.2e-13 0.045  
Time spent 
outdoors 
summer 0.047  2.1e-06 0.0022  0.033  1.3e-02 0.0011  BMI -0.006 7.4e-02 <0.001  
Time spent 
outdoors winter 0.028  3.8e-03 0.00077  0.036  7.9e-03 0.0013  BMI -0.0073 3.0e-02 <0.001  
Pulse rate 1 0.1  2.5e-23 0.01  0.13  4.0e-13 0.017  BMI 0.00012 9.7e-01 <0.001  
Pulse rate 2 0.091  2.5e-19 0.0083  0.1  9.0e-09 0.0099  BMI 
-
0.00057 8.7e-01 <0.001  
Height 0.25 6.5e-318 0.062  0.23 2.6e-132 0.054  Height 0.17 1.8e-17 0.03  
Acceleration 
force 0.07  7.5e-08 0.0049  0.098  4.1e-06 0.0096  Hand grip strength 0.014 4.5e-01 <0.001  
Hand grip 
strenght right 0.039  1.8e-09 0.0015  0.052  1.4e-08 0.0027  Hand grip strength -0.0051 7.9e-01 <0.001  
Forced vital 
capacity 0.03  7.4e-06 0.00092  0.045  1.1e-05 0.002  Hand grip strength 0.0081 6.7e-01 <0.001  
Forced 
expiratory 
volume 0.027  2.3e-04 0.00072  0.06  7.8e-08 0.0036  Hand grip strength 0.019 3.3e-01 <0.001  
Hand grip 
strength left 0.039  1.6e-09 0.0015  0.064  2.9e-12 0.0041  Hand grip strength -0.019 3.1e-01 <0.001  
Weight 0.39  0.0e+00 0.15  0.39 5.8e-231 0.15  Weight 0.19 1.2e-12 0.036  
Alcohol intake 0.074  1.0e-13 0.0055  0.096  2.9e-11 0.0092  
Frequence alcohol 
use (12mo) 0.06 4.3e-02 0.0036  
Amount alcohol 
drunk typical day 0.063  5.9e-08 0.0039  0.075  6.1e-06 0.0056  
Frequence alcohol 






Past tobacco use 0.043  1.7e-05 0.0019  0.076  2.2e-07 0.0057  FTND score 0.024 6.8e-01 <0.001  




smoked 0.066  1.0e-03 0.0043  0.053  4.9e-02 0.0028  FTND score 0.011 8.5e-01 <0.001  
Maternal 
smoking around 









Table S3: Variables with significantly lower brain-morphometricity estimates compared to the fsaverage – no smoothing processing 
We defined significance as non-overlapping confidence intervals of the morphometricity estimates in the UKB discovery sample. To account for multiple 
testing (9 tests for each of the 58 traits for which we observed significant morphometricity), we used 1-0.05/(9*58)=99.990% confidence intervals.   
We acknowledge this is a stringent definition of significance, which likely limited the statistical power of the test. Proper statistical testing was made 























Age_MRI x x x    x x x 
sex _f31_0_0 x x x x x  x x x 
body_mass_index_bmi_f21001_2_0 x x        
waist_circumference_f48_2_0 x x        
weight_f21002_2_0 x x        
hip_circumference_f49_2_0  x        
maternal_smoking_around_birth_f1787_2
_0 






Supplementary Dataset descriptions 
 
Dataset S1: Descriptive table of the UKB variables used in the analysis (for the discovery 
and replication UKB sets). Comparison between final sample participants excluded from 
the analysis due to failed processing and QC. UKB discovery and replication samples used 
in the analyses are further compared. 
 
Dataset S2: Descriptive table of the HCP variables used in the analysis and comparison 
with participants excluded from the analysis due to QC. 
 
Dataset S3: Detailed results of variance components analysis in the UKB (discovery and 
replication samples). Includes results presented in Figure 1a. Results include fixed effect 
associations (associations with covariates) as well as morphometricity. Baseline covariates 
are used in the first part of the table but results after accounting for height, weight and BMI 
are also presented. 
 
Dataset S4: Detailed results of variance components analysis in the HCP. Results of 
Figure 1b. 
 
Dataset S5: Grey-matter and residual correlations in the UKB. Table of the values 
presented in Figure 2a (UKB). The table contains correlations and p-values of the 
phenotypic and brain correlations. Format: r; (SE; p-value). 
 
Dataset S6: Grey-matter and residual correlations in the HCP. Table of the values 
presented in Figure 2b (HCP). The table contains correlations and p-values of the 
phenotypic and brain correlations. Format: r; (SE; p-value). 
  
Dataset S7: Association R
2
 between phenotypes and each ROI in the UKB discovery 
sample. Data is shown under the form of %variance (SE), p-value. This data corresponds to 
the Figure S8. Covariates include baseline + body size (height, weight and BMI). 
 
Dataset S8: Association R
2
 between body size phenotypes and each ROI in the UKB 
discovery sample. Data is shown under the form of %variance (SE), p-value. This data 
corresponds to the Figure S9. Baseline covariates only were used. 
 
Dataset S9: Association R
2
 between phenotypes and each ROI in the UKB replication 
sample. Data is shown under the form of %variance (SE), p-value.  
 
Dataset S10: Association R
2
 between phenotypes and each ROI in the HCP sample. Data is 
shown under the form of %variance (SE), p-value.  
 
Dataset S11: Brain-morphometricity results varying coarseness of cortical meshes in the 
UKB discovery sample. They are plotted in Figure 4. 
 
Dataset S12: Brain-morphometricity results varying smoothing and coarseness of cortical 
meshes in the UKB replication sample. All UKB phenotypes are included. They are 







Dataset S13: Accuracy from BLUP scores achieved using baseline covariates only. Results 
include 10-fold cross validation (UKB discovery), as well as prediction into UKB 
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